

Bare-metal Vascular Stents Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Bare-metal Vascular Stents market is experiencing steady growth, driven by increasing cardiovascular diseases and rising procedural volumes. The market size is projected to reach approximately $2.5 billion by 2027. Key trends include advancements in stent technology and regulatory developments impacting product availability and innovation in healthcare settings.
◍ Medtronic, plc (Ireland)
◍ Abbott Laboratories (U.S.)
◍ Boston Scientific Corporation (U.S.)
◍ BIOTRONIK SE & Co. KG (Germany)
◍ B. Braun Melsungen AG (Germany)
◍ Terumo Corporation (Japan)
◍ STENTYS SA (France)
The Bare-metal Vascular Stents Market features key players like Medtronic, Abbott, and Boston Scientific, driving growth through innovation, strategic partnerships, and expanding product portfolios. These companies enhance market presence via R&D and marketing strategies, addressing diverse vascular conditions. Notable revenues include:
- Medtronic: $30 billion
- Abbott: $43 billion
- Boston Scientific: $11 billion.
◍ MicroPort Scientific Corporation (China)
◍ Meril Life Sciences Pvt. Ltd. (India)
◍ Vascular Concepts (India)
◍ W. L. Gore and Associates (U.S.)
◍ C. R. Bard (U.S.)
◍ Endologix, Inc. (U.S.)
◍ Lombard Medical Technologies (U.K.)
◍ Translumina GmbH (Germany)
◍ JOTEC GmbH (Germany)
Request Sample Report
◍ Hospitals & Cardiac Centers
◍ Ambulatory Surgical Centers
◍ Coronary Stents
◍ Peripheral Stents
◍ Others
Request Sample Report
Request Sample Report
$ X Billion USD